Table: begin end state 1 20 cytoplasmic 21 43 transmembrane 44 48 non-cytoplasmic 49 68 transmembrane 69 106 cytoplasmic 107 129 transmembrane 130 134 non-cytoplasmic 135 154 transmembrane 155 164 cytoplasmic 165 187 transmembrane 188 206 non-cytoplasmic 207 232 transmembrane 233 252 cytoplasmic 253 271 transmembrane 272 289 non-cytoplasmic 290 314 transmembrane 315 338 cytoplasmic 339 360 transmembrane 361 365 non-cytoplasmic 366 387 transmembrane 388 407 cytoplasmic 408 431 transmembrane 432 436 non-cytoplasmic 437 454 transmembrane 455 474 cytoplasmic
Input: >RR42_RS33780 MIHHQQQQQSSGLKHGLKQRHMTMIALGGVIGAGLFVGSGVVIKSAGPAAVISFLITGLL VVLVMRMLGEMACALPTVGSFYEYAREAWSDRPAMGELAGFLTGWMYWYFWVIVVALEAV AGASLVQFWLPGVPAWSISLVLLVMLTLTNLISVKSFGEFEFWFASIKVAAIVVFLFLAG LFVLGMWPGATASVAHLTVHGGFAPNGIMPVLTGAVAATGFYFGAEIVTIAAAETAEPQK AVARATSSVITRVLVFYVGSVLLVVCLVPWNSAGIATPYVSALNAMRIPAAAQIMNAVVL TAVLSALNSGLYASSRMLFALTKRGDAPKALARLSRNGVPVRAILFATLFGYGAVVMSYV SPDKVFAFLVNSYGTVAIFVYILIAISQLRLRARLEREAPHRLKVRMWAFPYLTWVAIAG MVGIVVAMAFIPDQRTPLLLGVASLGILVVAYAVRQQLRKHAAAAPLGEVRRAD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server